Cite
N-acetylcysteine for depression and glutamate changes in the left prefrontal cortex in adolescents and young adults at risk for bipolar disorder: A pilot study.
MLA
Nery, Fabiano G., et al. “N-Acetylcysteine for Depression and Glutamate Changes in the Left Prefrontal Cortex in Adolescents and Young Adults at Risk for Bipolar Disorder: A Pilot Study.” Early Intervention in Psychiatry, vol. 16, no. 2, Feb. 2022, pp. 195–99. EBSCOhost, https://doi.org/10.1111/eip.13149.
APA
Nery, F. G., Tallman, M. J., Cecil, K. M., Blom, T. J., Patino, L. R., Adler, C. M., & DelBello, M. P. (2022). N-acetylcysteine for depression and glutamate changes in the left prefrontal cortex in adolescents and young adults at risk for bipolar disorder: A pilot study. Early Intervention in Psychiatry, 16(2), 195–199. https://doi.org/10.1111/eip.13149
Chicago
Nery, Fabiano G, Maxwell J Tallman, Kim M Cecil, Thomas J Blom, Luis R Patino, Caleb M Adler, and Melissa P DelBello. 2022. “N-Acetylcysteine for Depression and Glutamate Changes in the Left Prefrontal Cortex in Adolescents and Young Adults at Risk for Bipolar Disorder: A Pilot Study.” Early Intervention in Psychiatry 16 (2): 195–99. doi:10.1111/eip.13149.